KOREA WHO
-
-
-
Chairwoman of Hanmi Pharm Group
Song Young-sook
End of Management Dispute, Focus on Supporting Professional Leadership as Major Shareholder
-
Last Updated on Apr 18, 2025
-
Chairwoman of Hanmi Pharm Group
Life Summary
Song Young-sook is the chairwoman of Hanmi Pharm Group.
She stepped back from active management after resolving a management rights dispute with her two sons—Lim Jong-yun, chairman of KORI Group, and Lim Jong-hoon, inside director of Hanmi Science.
However, as chairwoman of the group and a major shareholder of the holding company Hanmi Science, she continues to play a supportive role in establishing a professional management system.
She was born in September 1948 in Gimcheon, Gyeongsangbuk-do.
She graduated from the Department of Education at Sookmyung Women’s University in 1970.
She is the widow of the late Lim Sung-ki, former chairman of Hanmi Pharm, who passed away in August 2020, and succeeded him in leading the Hanmi Pharm Group.
Although she clashed with her two sons over the direction of the group’s management, she gained the upper hand by persuading Shin Dong-guk, chairman of Hanyang Precision and the largest individual shareholder of Hanmi Science.
At the time, Song proposed the adoption of a management model like that of global pharmaceutical company Merck and advocated for the establishment of a professional executive system. This approach brought the year-long management dispute to an end. She resigned from her positions as CEO and inside director of Hanmi Science.
#SongYoungsook #HanmiPharmGroup #HanmiScience #LimSungki #Merckmodel #managementdispute #professionalmanagement #Koreanpharma #secondgenerationconflict #SookmyungUniversity
She stepped back from active management after resolving a management rights dispute with her two sons—Lim Jong-yun, chairman of KORI Group, and Lim Jong-hoon, inside director of Hanmi Science.
However, as chairwoman of the group and a major shareholder of the holding company Hanmi Science, she continues to play a supportive role in establishing a professional management system.
She was born in September 1948 in Gimcheon, Gyeongsangbuk-do.
She graduated from the Department of Education at Sookmyung Women’s University in 1970.
She is the widow of the late Lim Sung-ki, former chairman of Hanmi Pharm, who passed away in August 2020, and succeeded him in leading the Hanmi Pharm Group.
Although she clashed with her two sons over the direction of the group’s management, she gained the upper hand by persuading Shin Dong-guk, chairman of Hanyang Precision and the largest individual shareholder of Hanmi Science.
At the time, Song proposed the adoption of a management model like that of global pharmaceutical company Merck and advocated for the establishment of a professional executive system. This approach brought the year-long management dispute to an end. She resigned from her positions as CEO and inside director of Hanmi Science.
#SongYoungsook #HanmiPharmGroup #HanmiScience #LimSungki #Merckmodel #managementdispute #professionalmanagement #Koreanpharma #secondgenerationconflict #SookmyungUniversity